Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Regranex | becaplermin | Smith+Nephew | N-103691 RX | 1997-12-16 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
regranex | Biologic Licensing Application | 2023-12-11 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
diabetic neuropathies | EFO_1000783 | D003929 | — |
Code | Description |
---|---|
S0157 | Becaplermin gel 0.01%, 0.5 gm |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetic foot | D017719 | EFO_1001459 | — | — | — | 1 | — | 2 | 3 |
Diabetic neuropathies | D003929 | EFO_1000783 | — | — | — | 1 | — | 1 | 2 |
Foot ulcer | D016523 | — | — | — | — | 1 | — | 1 | 2 |
Ulcer | D014456 | MPATH_579 | — | — | — | 1 | — | — | 1 |
Skin ulcer | D012883 | — | L98.4 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Burns | D002056 | — | T30.0 | — | 1 | — | — | — | 1 |
Electric burns | D002058 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | — | 2 | 2 |
Neoplasms | D009369 | — | C80 | — | — | — | — | 1 | 1 |
Drug common name | Becaplermin |
INN | becaplermin |
Description | Platelet-derived growth factor, B chain precursor (PDGF B-chain) (Platelet-derived growth factor beta polypeptide) |
Classification | Protein |
Drug class | growth factors: platelet derived growth factors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201556 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00102 |
UNII ID | 1B56C968OA (ChemIDplus, GSRS) |